Sophia Genetics Sa (SOPH)

Mar 18, 2025, 9:00 AM EDT - 14 days ago

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

Mar 4, 2025, 2:32 PM EST - 4 weeks ago

SOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 6:45 AM EST - 4 weeks ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Feb 24, 2025, 4:00 AM EST - 5 weeks ago

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

AZN

Feb 18, 2025, 8:30 AM EST - 6 weeks ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

Jan 28, 2025, 8:46 AM EST - 2 months ago

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

Nov 21, 2024, 5:30 AM EST - 4 months ago

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Nov 5, 2024, 2:46 PM EST - 5 months ago

SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 6:32 AM EST - 5 months ago

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

Nov 5, 2024, 6:30 AM EST - 5 months ago

SOPHiA GENETICS Reports Third Quarter 2024 Results

Oct 22, 2024, 6:45 AM EDT - 5 months ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

Sep 14, 2024, 9:00 AM EDT - 7 months ago

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

Sep 12, 2024, 7:00 AM EDT - 7 months ago

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

Sep 12, 2024, 4:00 AM EDT - 7 months ago

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

Sep 10, 2024, 10:16 AM EDT - 7 months ago

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

AZN

Sep 5, 2024, 8:30 AM EDT - 7 months ago

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

Sep 4, 2024, 6:00 AM EDT - 7 months ago

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

Aug 28, 2024, 1:30 PM EDT - 7 months ago

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

Aug 14, 2024, 3:00 AM EDT - 8 months ago

SOPHiA DDM™ Platform Certified Under IVDR

Aug 6, 2024, 6:45 AM EDT - 8 months ago

SOPHiA GENETICS Reports Second Quarter 2024 Results

Jul 29, 2024, 10:30 AM EDT - 8 months ago

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

Jul 24, 2024, 11:59 AM EDT - 8 months ago

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 24, 2024, 10:00 AM EDT - 8 months ago

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 23, 2024, 6:45 AM EDT - 9 months ago

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

Jul 4, 2024, 2:30 AM EDT - 9 months ago

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

Jun 24, 2024, 9:47 AM EDT - 10 months ago

SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting

Jun 24, 2024, 2:00 AM EDT - 10 months ago

SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

Jun 13, 2024, 6:00 AM EDT - 10 months ago

SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform

May 30, 2024, 12:19 PM EDT - 10 months ago

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

May 29, 2024, 10:00 AM EDT - 10 months ago

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

May 20, 2024, 10:02 AM EDT - 11 months ago

SOPHiA GENETICS Announces Instituto Mário Penna as New Customer

May 16, 2024, 6:02 AM EDT - 11 months ago

Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS

May 12, 2024, 2:46 AM EDT - 11 months ago

SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript

May 7, 2024, 6:45 AM EDT - 11 months ago

SOPHiA GENETICS Reports First Quarter 2024 Results

Apr 30, 2024, 7:05 AM EDT - 1 year ago

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Apr 23, 2024, 10:29 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

Apr 23, 2024, 5:05 AM EDT - 1 year ago

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

Apr 17, 2024, 6:05 AM EDT - 1 year ago

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

Apr 4, 2024, 1:00 AM EDT - 1 year ago

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

Apr 2, 2024, 10:00 AM EDT - 1 year ago

Laboratorio Barnafi-Krause is Live on SOPHiA DDM™

Mar 20, 2024, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

Mar 15, 2024, 6:00 AM EDT - 1 year ago

SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

Mar 7, 2024, 12:07 PM EST - 1 year ago

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference

Mar 5, 2024, 10:46 AM EST - 1 year ago

SOPHiA GENETICS SA (SOPH) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 6:45 AM EST - 1 year ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

Feb 22, 2024, 8:45 AM EST - 1 year ago

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference

Feb 20, 2024, 10:46 AM EST - 1 year ago

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024

Feb 7, 2024, 6:51 AM EST - 1 year ago

SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

AZN

Jan 25, 2024, 10:50 AM EST - 1 year ago

SOPHiA GENETICS Supports Genetic Testing in Brazil

Jan 18, 2024, 3:00 PM EST - 1 year ago

SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio